Medtronic, Inc. (MDT)
-NYSE | Prev Close: | 49.89 |
|---|
| Open: | N/A |
|---|
| Bid: | 48.05 x 300 |
|---|
| Ask: | 51.24 x 300 |
|---|
| 1y Target Est: | 50.29 |
|---|
| Beta: | 1.02 |
|---|
| Next Earnings Date: | 21-May-13 |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 35.67 - 50.17 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 4,080,800 |
|---|
| Market Cap: | 50.58B |
|---|
| P/E (ttm): | 14.76 |
|---|
| EPS (ttm): | 3.38 |
|---|
| Div & Yield: | 1.04 (2.10%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Medtronic CoreValve ADVANCE Study Demonstrates Low Rates of Mortality and Stroke and Sustained Valve PerformanceThomson Reuters ONE(Tue 4:02AM EDT)
- Medtronic Finds TAVI with CoreValve® System Cost Effective for Treating Patients with Severe Aortic StenosisThomson Reuters ONE(Tue 4:02AM EDT)
- Medtronic Announces Data From Largest Real-World Patient Population Confirm Strong Safety Profile and Clinical Efficacy of Renal Denervation with the Symplicity(TM) SystemThomson Reuters ONE(Tue 4:02AM EDT)
- Medtronic's Multi-Electrode, Simultaneously Firing Renal Denervation Catheter Shows Reduced Procedure Times While Demonstrating Significant Blood Pressure ReductionThomson Reuters ONE(Tue 4:02AM EDT)
- Medtronic Device Safely Fixes Aortic Value in Studyat Bloomberg(Tue 4:00AM EDT)
- Final Glance: Medical Devices companiesAP(Mon, May 20)
- Midday Glance: Medical Devices companiesAP(Mon, May 20)
- Forbes Earnings Preview: Medtronicat Forbes(Mon, May 20)
- Medtronic Earnings: Your Sneak Peek to the Big Announcementat Wall St. Cheat Sheet(Mon, May 20)
- Medtronic to Honor Those Who Give Back After Receiving Life-Enhancing Medical TechnologyThomson Reuters ONE(Mon, May 20)
- Will Obamacare Crush Medtronic's Earnings?at Motley Fool(Mon, May 20)
- Early Glance: Medical Devices companiesAP(Mon, May 20)
- U.S. Supreme Court agrees to hear Medtronic patent caseat Reuters(Mon, May 20)
- Supreme Court agrees to hear Medtronic-Boston Scientific patent caseat theflyonthewall.com(Mon, May 20)
- InPlay: Medtronic receives CE mark for 'Export Advance' aspiration catheterBriefing.com(Mon, May 20)
Key Statistics
| Forward P/E (1 yr): | 12.99 |
|---|
| P/S (ttm): | 3.08 |
|---|
| Ex-Dividend Date: | 03-Apr-13 |
|---|
Analysts
| Annual EPS Est
(Apr-13)
: | 3.69 |
|---|
| Quarterly EPS Est
(Apr-13)
: | 1.03 |
|---|
| Mean Recommendation*: | 2.3 |
|---|
| PEG Ratio (5 yr expected): | 2.08 |
|---|
Business Summary
Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. It provides products to diagnose, treat, and manage heart rhythm disorders and heart failure, including implantable cardiac pacemakers, implantable cardioverter defib...
View More